المؤلفون: Christian Rummey, F. Schärer, Michael Erb, C. Mondadori, Robert Dallmann, B. Cardel, Daniel L. Marks, Philipp Weyermann, Isabelle Courdier-Fruh, H. Siendt, M. Hufschmid, K. Bray-French, H. Herzner, Michael Soeberdt, M. Boroff, J. Dubach-Powell, Achim Feurer, N. Güven, Marco Henneböhle, H. Deppe, G. Santos, S. Nordhoff, Mariusz Papp, M. Terinek, Corinne Anklin, L. T. Sumanovski, Roman Haefeli

المساهمون: University of Zurich, Dallmann, R

المصدر: Journal of Cachexia, Sarcopenia and Muscle

مصطلحات موضوعية: medicine.medical_specialty, Mouse, 10050 Institute of Pharmacology and Toxicology, 610 Medicine & health, Metabolic rate, Pharmacology, Cachexia, 2732 Orthopedics and Sports Medicine, 2737 Physiology (medical), Food intake, Physiology (medical), Internal medicine, medicine, Melanocortin-4 receptor antagonist, Orthopedics and Sports Medicine, Mode of action, Receptor, C26 adenocarcinoma, business.industry, digestive, oral, and skin physiology, Antagonist, Cancer cachexia, medicine.disease, Blockade, Melanocortin 4 receptor, Endocrinology, Drug development, 570 Life sciences, biology, Original Article, Melanocortin, business, hormones, hormone substitutes, and hormone antagonists

وصف الملف: Dallmann_Brown_TheOrcallyActiveMelanoc_2011.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028f0b6a7b1c6923583284d8bca22f61
https://doi.org/10.1007/s13539-011-0039-1

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.